Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Lead
Yong Fang
With
This multicentre randomised controlled clinical trial conducted in China include phase I study and phase II study. Phase I study: to get the maximum tolerated dose of anlotinib when combined with Docetaxel. Phase II study: to compare the effectiveness and safety of Anlotinib Plus Docetaxel in patients of EGFR wild-type Advanced Non-squamous Non-small Cell Lung Cancer.
Age
18–75
Sex
ALL
Healthy volunteers
Not accepted